1. Anti-infection
  2. Antibiotic
  3. Hispolon

Hispolon, a polyphenol, can be isolated from Phellinus linteus. Hispolon possesses anticancer, antidiabetic, antioxidant, antiviral, hepatoprotective, anti-diabetic, and anti-inflammatory activities.

For research use only. We do not sell to patients.

Hispolon

Hispolon Chemical Structure

CAS No. : 173933-40-9

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Hispolon:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Hispolon, a polyphenol, can be isolated from Phellinus linteus. Hispolon possesses anticancer, antidiabetic, antioxidant, antiviral, hepatoprotective, anti-diabetic, and anti-inflammatory activities[1].

Cellular Effect
Cell Line Type Value Description References
A10 IC50
37.05 μg/mL
Compound: 1
Antiproliferative activity against rat A10 cells after 24 hrs by MTT assay
Antiproliferative activity against rat A10 cells after 24 hrs by MTT assay
[PMID: 22967007]
A549 IC50
0.183 μM
Compound: 8
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
[PMID: 15165144]
BGC-823 IC50
0.205 μM
Compound: 8
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
[PMID: 15165144]
Bel-7402 IC50
0.038 μM
Compound: 8
Cytotoxicity against human Bel7402 cells after 96 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 96 hrs by MTT assay
[PMID: 15165144]
DU-145 IC50
28.6 μM
Compound: VA-1
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
[PMID: 25842364]
HCT-116 IC50
5.2 μM
Compound: VA-1
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
[PMID: 25842364]
HCT-8 IC50
0.199 μM
Compound: 8
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
[PMID: 15165144]
HEK293 IC50
7.3 μM
Compound: VA-1
Cytotoxicity against HEK293 cells expressing pcDNA3.1 after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells expressing pcDNA3.1 after 72 hrs by MTT assay
[PMID: 25842364]
HEK293 IC50
9.6 μM
Compound: VA-1
Cytotoxicity against HEK293 cells expressing ABCB1 after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells expressing ABCB1 after 72 hrs by MTT assay
[PMID: 25842364]
KETR3 IC50
0.206 μM
Compound: 8
Cytotoxicity against human Ketr3 cells after 96 hrs by MTT assay
Cytotoxicity against human Ketr3 cells after 96 hrs by MTT assay
[PMID: 15165144]
MCF7 IC50
0.025 μM
Compound: 8
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
[PMID: 15165144]
MCF7 IC50
7.9 μM
Compound: VA-1
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 25842364]
MDA-MB-231 IC50
32.2 μM
Compound: VA-1
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
[PMID: 25842364]
MDCK IC50
36.2 μM
Compound: VA-1
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
[PMID: 25842364]
NIH3T3 IC50
51.2 μM
Compound: VA-1
Cytotoxicity against mouse NIH/3T3 cells after 72 hrs by MTT assay
Cytotoxicity against mouse NIH/3T3 cells after 72 hrs by MTT assay
[PMID: 25842364]
PC-3 IC50
12.9 μM
Compound: VA-1
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
[PMID: 25842364]
S1 IC50
8.4 μM
Compound: VA-1
Cytotoxicity against human S1 cells after 72 hrs by MTT assay
Cytotoxicity against human S1 cells after 72 hrs by MTT assay
[PMID: 25842364]
In Vitro

Hispolon (25 and 50 μM, 24-72 h) inhibits cell viability of U87MG cells[2].
Hispolon (25 and 50 μM, 24, 48 h) induces G2/M cell cycle arrest and apoptosis in U87MG cells[2].
Hispolon (25 and 50 μM, 2-8 h) decreases the expression of G1–S transition-related protein cyclin D4 but increases the expression of CDK inhibitor p21[2].
Hispolon (25 and 50 μM, 24 h) inhibits the migration of U87MG cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: U87MG cells
Concentration: 25 and 50 μM
Incubation Time: 24, 48, 72 h
Result: Inhibited cell viability in a dose and time dependent way.

Western Blot Analysis[2]

Cell Line: U87MG cells
Concentration: 25 and 50 μM
Incubation Time: 2, 4, 8 h
Result: Decreased cyclin D4 level, and increased p21 level.
In Vivo

Hispolon (2.5-10 mg/kg, i.p.) attenuates LPS-induced acute lung injury in mice[3].
Hispolon (5 and 10 mg/kg, s.c.) reduces tumor growth in DBTRG xenograft mice[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LPS-induced acute lung injury mice[3]
Dosage: 2.5, 5 and 10 mg/kg
Administration: Intraperitoneal injection (i.p.)
Result: Alleviated the pathological effects in the LPS-challenged mouse.
Reduced the W/D ratio in the lung and MPO activity.
Decreased pro-Inflammatory cytokine production.
Animal Model: DBTRG xenograft mice[4]
Dosage: 5 and 10 mg/kg
Administration: Subcutaneous injection (s.c.)
Result: Reduced tumor volume (RTV).
Inhibited GBM cell proliferation in vivo upon HE and ki-67 staining.
Molecular Weight

220.22

Formula

C12H12O4

CAS No.
Appearance

Solid

Color

Light yellow to yellow

SMILES

CC(/C=C(O)/C=C/C1=CC(O)=C(C=C1)O)=O

Structure Classification
Initial Source

Phellinus linteus

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (454.09 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.5409 mL 22.7046 mL 45.4091 mL
5 mM 0.9082 mL 4.5409 mL 9.0818 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.42%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.5409 mL 22.7046 mL 45.4091 mL 113.5228 mL
5 mM 0.9082 mL 4.5409 mL 9.0818 mL 22.7046 mL
10 mM 0.4541 mL 2.2705 mL 4.5409 mL 11.3523 mL
15 mM 0.3027 mL 1.5136 mL 3.0273 mL 7.5682 mL
20 mM 0.2270 mL 1.1352 mL 2.2705 mL 5.6761 mL
25 mM 0.1816 mL 0.9082 mL 1.8164 mL 4.5409 mL
30 mM 0.1514 mL 0.7568 mL 1.5136 mL 3.7841 mL
40 mM 0.1135 mL 0.5676 mL 1.1352 mL 2.8381 mL
50 mM 0.0908 mL 0.4541 mL 0.9082 mL 2.2705 mL
60 mM 0.0757 mL 0.3784 mL 0.7568 mL 1.8920 mL
80 mM 0.0568 mL 0.2838 mL 0.5676 mL 1.4190 mL
100 mM 0.0454 mL 0.2270 mL 0.4541 mL 1.1352 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Hispolon
Cat. No.:
HY-150521
Quantity:
MCE Japan Authorized Agent: